SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-11-223373
Filing Date
2011-08-15
Accepted
2011-08-15 17:15:22
Documents
11
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 884668
2 AMENDED AND RESTATED EXCLUSIVE LICENSE AGREEMENT dex105.htm EX-10.5 183031
3 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 6029
4 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 6095
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 5690
  Complete submission text file 0001193125-11-223373.txt   3313578

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT abio-20110630.xml EX-101.INS 353126
7 XBRL TAXONOMY EXTENSION SCHEMA abio-20110630.xsd EX-101.SCH 23016
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abio-20110630_cal.xml EX-101.CAL 39190
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abio-20110630_def.xml EX-101.DEF 66440
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE abio-20110630_lab.xml EX-101.LAB 178806
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abio-20110630_pre.xml EX-101.PRE 129435
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-22873 | Film No.: 111037730
SIC: 2835 In Vitro & In Vivo Diagnostic Substances